Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kura Oncology, Inc. | CCO & Chief Strategy Officer | Common Stock | 20.6K | $237K | $11.50 | Jan 27, 2023 | Direct |
Comera Life Sciences Holdings, Inc. | Director | Stock Option (Right to Purchase) | 111K | Nov 9, 2023 | Direct | ||
PMV Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 67.5K | Jun 6, 2024 | Direct |